Definitive Contract 75D30118C02645
- Not listed
- Emory University is receiving $348,253.49 under a firm fixed price definitive contract from the Department of Health and Human Services Centers for Disease Control and Prevention. The contract was awarded on September 30th, 2020 to support COVID-19 BAA Topic 2 efforts, with work expected to be completed by March 28th, 2022. No set-aside designation was specified. Emory University will serve as the prime contractor, engaged to assist the CDC in assessing cloth face coverings as a means of...
- This firm fixed-price purchase order was awarded to Emory University, a private research institution in Atlanta, Georgia, by the Centers for Disease Control and Prevention (CDC) Pittsburgh office. The $90,000.00 contract is for an IRB-approved study under the Emory University Center for AIDS Research. The contract has no set-aside designation and is set to be completed by September 20, 2022. Emory University, through its Office of Sponsored Programs Division, has an extensive track record of...
- The Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) awarded a $249,000.00 firm fixed-price purchase order to Emory University's Office of Sponsored Programs Division for biologicals. The work will be performed in Atlanta, Georgia and have a completion date of June 30, 2023. The contract is not set aside for a designated socioeconomic group. Emory University is a private research university that has a history of providing clinical trial, data...
- Emory University Office of Sponsored Programs Division was awarded a $96,146 firm fixed price contract by the Centers for Disease Control and Prevention for support of the SARS COV-2 Broad Agency Announcement. No set-aside designation was applied. Work will be performed in Atlanta, Georgia through March 2022. This contract is likely associated with Emory University's previously awarded multiple award indefinite delivery contract from the CDC worth up to $86 million to provide clinical...
- This is a $695,773 firm-fixed-price definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Emory University, a private research university located in Atlanta, Georgia. The contract is for an MSM PREP STUDY with a performance period through September 22, 2023. The contract does not have a set-aside designation. Emory University is an experienced federal contractor, having received numerous prime contracts and subcontracts from agencies such as the Department of...
- This is a federal purchase order contract awarded by the Centers for Disease Control and Prevention (CDC) to Emory University, a private research institution located in Atlanta, Georgia. The contract, valued at $149,995.00, is for a PREP (Pandemic and All-Hazards Preparedness) study with a period of performance from September 23, 2016 to February 28, 2018. The contract is a firm fixed-price type and does not have a set-aside designation. Emory University, through its Office of Sponsored Programs...
- Emory University, operating as Emory University Office of Sponsored Programs Division, has been awarded a definitive contract by the Centers for Disease Control and Prevention (CDC) to perform work relating to determining antigenic drift with human monoclonal antibodies to hemagglutinin. Valued at approximately $901,182, this firm fixed price contract will be performed in Atlanta, Georgia over a two-year period concluding in September 2021. As part of its broader infectious disease programs, the...
- The federal contract award 75D30121C10084 was issued by the Centers for Disease Control and Prevention (CDC) to Emory University for "SARS - COV-2 APPLIED RESEARCH FOR NCEZID". The $622,108.90 firm-fixed price contract runs through November 28, 2022 and does not have a set-aside designation. Emory University, a private research university based in Atlanta, Georgia, has an extensive track record of performing federally funded research and providing services to the government. This...
- This $248,000.00 firm fixed price purchase order contract was awarded by the Centers for Disease Control and Prevention (CDC) Pittsburgh office, a civilian federal agency, to Emory University's Office of Sponsored Programs Division. The contract is for the production of highly purified proteins and structure determination, with a performance period through September 11, 2025. Emory University, a private research institution in Atlanta, Georgia, has an extensive track record of conducting...
- Emory University is providing clinical immunization safety assessment support services to the Centers for Disease Control and Prevention under a multiple award indefinite delivery contract. The contract has a potential value of $289,331.70 and was awarded on July 17, 2020 without a set-aside designation. Work will be performed in Atlanta, Georgia and must be completed by September 30, 2020. As a leading research university, Emory University will utilize its expertise in public health research to...
Emory University was awarded a $913,592 firm fixed-price definitive contract by the Centers for Disease Control and Prevention (CDC) Pittsburgh on September 1, 2018, to conduct an Elastomeric Respirator Study. The contract, which was not set aside for any socioeconomic category, was completed by August 31, 2023, with work performed in Atlanta, Georgia. The study appears to focus on evaluating the feasibility and effectiveness of elastomeric respirators, likely in support of CDC's occupational health and safety initiatives for healthcare workers and other at-risk populations. Georgia State University Research Foundation Inc. served as a major subcontractor on the award, receiving a sub-contract in February 2020 for elastomeric respirator feasibility and effectiveness training for healthcare workers. This collaborative arrangement leverages Emory University's established research capabilities in biomedical and public health investigations alongside Georgia State University Research Foundation's expertise in research implementation and workforce training. The partnership reflects the CDC's strategy of engaging academic research institutions to support evidence-based evaluations of protective equipment and worker safety protocols.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Respirator Study: Assessment of Elastomeric Respirators in Healthcare Delivery Settings | 2018-N-67799 | Department of Health and Human Services Centers for Disease Control and Prevention Pittsburgh | Pre-Solicitation 1/1 | 4/4/18, 8:38 AM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00008 | Other Administrative Action | $0 | 12/2/25 | |
| P00007 | Other Administrative Action | $0 | 3/30/22 | |
| P00006 | Other Administrative Action | $0 | 2/25/22 | |
| P00005 | Supplemental Agreement for work within scope | $0 | 9/30/21 | |
| P00004 | Other Administrative Action | $0 | 5/20/20 |